SCHEMBL811980

SCHEMBL811980

Cc1ccccc1C[C]=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.52
PTGS1 P23219 1/20 0.44
PTGS2 P35354 1/20 0.44
ACHE P22303 2/20 0.41
TSHR P16473 1/20 0.41
ALDH1A1 P00352 3/20 0.40
HPGD P15428 2/20 0.40
CTBP2 P56545 1/20 0.40
CHRM2 P08172 1/20 0.39
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
CYP2A13 Q16696 1/20 0.37
HTT P42858 1/20 0.37
GAA P10253 1/20 0.37
DAO P14920 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6317062 0.82 ESR1 (0.41) TAAR1TSHRALDH1A1SMN1; SMN2MAPT
SCHEMBL11480751 0.82 GABRA1 (0.36) TAAR1ALDH1A1HPGDKMT2ALMNA
SCHEMBL1610575 0.81 TAAR1 (0.46) TAAR1PTGS1PTGS2ACHETSHR
SCHEMBL16952334 0.79 GABRA1 (0.38) TAAR1PTGS1PTGS2ALDH1A1
SCHEMBL3246235 0.79 TAAR1 (0.50) TAAR1PTGS1PTGS2ALDH1A1HPGD
SCHEMBL96154 0.78 GABRA1 (0.45) TAAR1ALDH1A1MAPTKDM4EGAA
SCHEMBL910442 0.77 TAAR1 (0.54) TAAR1PTGS1PTGS2ACHETSHR
SCHEMBL11687737 0.76 TAAR1 (0.46) TAAR1PTGS1PTGS2ACHETSHR
SCHEMBL102904 0.76 ALDH1A1 (0.47) TAAR1PTGS1PTGS2ACHETSHR
SCHEMBL3645165 0.76 TAAR1 (0.46) TAAR1PTGS1PTGS2ACHETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3743061-A1 CANNABINOIDS AND DERIVATIVES FOR PROMOTING IMMUNOGENICITY OF TUMOR AND INFECTED CELLS Pascal Biosciences Inc. (CA) 2020-12-02 EP claimed
US-RE48335-E1 Polymyxin derivatives as antimicrobial compounds MONASH UNIVERSITY (AU) 2020-12-01 US claimed
WO-2019144126-A1 CANNABINOIDS AND DERIVATIVES FOR PROMOTING IMMUNOGENICITY OF TUMOR AND INFECTED CELLS PASCAL BIOSCIENCES INC. (CA) 2019-07-25 WO claimed
CN-109803956-A Novel benzamide compounds, preparation method and acaricide 杀虫剂(印度)有限公司 2019-05-24 CN claimed
CN-108290919-A Azithromycin derivatives having epithelial barrier enhancing properties 艾比恩多制药有限责任公司 2018-07-17 CN claimed
US-20170137469-A1 POLYMYXIN DERIVATIVES AS ANTIMICROBIAL COMPOUNDS MONASH UNIVERSITY (AU) 2017-05-18 US claimed
EP-3126376-A1 POLYMYXIN DERIVATIVES AS ANTIMICROBIAL COMPOUNDS Monash University (AU) 2017-02-08 EP claimed
CN-105198861-A 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides FMC COMPANY 2015-12-30 CN claimed
WO-2015149131-A1 POLYMYXIN DERIVATIVES AS ANTIMICROBIAL COMPOUNDS MONASH UNIVERSITY (AU) 2015-10-08 WO claimed
WO-2015109451-A1 SYNTHESIS OF COMPOUNDS CONTAINING 8-OXA-3-AZABICYCLO (3.2.1)OCTANE RING RHODIA OPERATIONS (FR) 2015-07-30 WO claimed
EP-0925063-A1 HYPOGLYCEMIC AND HYPOLIPIDEMIC COMPOUNDS ELI LILLY AND COMPANY (US) 1999-06-30 EP claimed
WO-1998000137-A1 HYPOGLYCEMIC AND HYPOLIPIDEMIC COMPOUNDS ELI LILLY AND COMPANY (US) 1998-01-08 WO claimed
WO-1998000403-A1 HYPOGLYCEMIC AND HYPOLIPIDEMIC COMPOUNDS ELI LILLY AND COMPANY (US) 1998-01-08 WO claimed
CN-1150801-A N-cyanoaryl nitrogen heterocyclic compounds BAYER AG (DE) 1997-05-28 CN claimed
CN-1146763-A Heterocyclic benzonitrile BAYER AG (DE) 1997-04-02 CN claimed
EP-0469887-B1 Acetamide derivatives ZENECA LTD (GB) 1994-12-14 EP claimed
US-5270342-A Acetamide derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-12-14 US claimed
EP-0469887-A1 Acetamide derivatives ZENECA LIMITED (GB) 1992-02-05 EP claimed
US-5049551-A Antitumor UBE INDUSTRIES, LTD. (JP) 1991-09-17 US claimed
US-3953596-A 8-Oxa-3-azabicyclo(3.2.1)octane analgesic compositions and method of alleviating pain in animals ICI UNITED STATES INC. (US) 1976-04-27 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170137469-A1 POLYMYXIN DERIVATIVES AS ANTIMICROBIAL COMPOUNDS VIP, PEPD, NRDC TAAR1 4703/4885PTGS1 1772/4885PTGS2 2615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.